Erenumab, injected monthly at 140 mg, can effectively induce remission of nonopioid medication overuse headache (MOH) in patients with chronic migraine within 6 months. The treatment also ...
After 12 weeks of treatment, the participants reported ... “Today, about 3 million patients in the U.S. suffer from chronic migraine attacks that are resistant to conventional therapies ...
A nationally representative study of Medicare beneficiaries with modest incomes found that up to half of them may not have sufficient funds to cover out-of-pocket costs associated with a single ...
Botox (botulinum toxin type A) is also used by the NHS for the treatment of chronic migraine in adults, defined as having at least 15 headache days a month. Helen Knight, director of medicines ...
The trial is designed to evaluate the safety and effectiveness of the company's Migraine Therapy System in patients who have failed current medical therapies and have treatment-resistant chronic ...
Shiratronics Inc. raised $66 million in an oversubscribed series B financing round to support completion of its recently launched clinical trial to evaluate the safety and efficacy of its ...
The trial is designed to evaluate the safety and effectiveness of the company's Migraine Therapy System in patients who have failed current medical therapies and have treatment-resistant chronic ...